IRCT20200213046484N1
Not yet recruiting
Phase 3
The effects of different doses of midazolam and preoperative anxiety on retrograde and anterograde amnesia in patients undergoing abdominal laparotomy under general anesthesia
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- anxiety.
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 120
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •120 patients aged 20 to 60 years at risk of ASA1\-2 undergoing non\-emergency abdominal laparotomy undergoing GA at Rasool Akram Hospital
Exclusion Criteria
- •Patients with ASAIII risk
- •The Pregnant patient
- •Patients with psychiatric disorders or receiving sedative and antipsychotic medications
- •Mental dysfunction
- •Patients with visual or hearing impairment
- •Patients with liver and kidney dysfunction
- •Previous use of benzodiazepine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
se of midazolam in different doses to prevent muscle movements caused by etomidateHealth Condition 1: null- Surgery under general anaesthesiaCTRI/2017/11/010382niversity College of Medical Sciences and GTB Hospital164
Completed
Phase 4
Investigating the effects of three drugs, midazolam, propofol and dexmedetomidine, on hemodynamic changes in cataract surgery patients.IRCT20221020056250N1Gorgan University of Medical Sciences110
Recruiting
Phase 3
The effect of midazolam on the improvement of hysteria symptomsHysterical patients.Dissociative and conversion disordersIRCT20220516054869N4Zahedan University of Medical Sciences80
Recruiting
Phase 3
Comparison of the effect of adding midazolam, paracetamol, tramadol and magnesium sulphate to ?ropivacaine in reducing paiIRCT20141209020258N168Arak University of Medical Sciences160
Completed
Phase 3
Comparison of low dose midazolam and etomidate for the Prevention of myoclonic Movements following etomidate Injection.Myoclonic Movements.IRCT20160307026950N6Esfahan University of Medical Sciences120